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Abstract: Withania somnifera (ashwagandha) contains many biologically active constituents used for the prevention and 
treatment of various diseases. The aim of the current study was to evaluate the impact of Energy of Consciousness Healing 
Treatment (The Trivedi Effect
®
) on the characteristic properties of the ashwagandha root extract using LC-MS, GC-MS, and 
NMR spectroscopy. Ashwagandha root extract was divided into two parts – one part was control (without treatment), while 
another part was treated with the Energy of Consciousness Healing Treatment remotely by twenty renowned Biofield 
Energy Healers and defined as the Biofield Energy Treated sample. LC-MS data revealed that the retention time of the 
phytoconstituents remained same in the control and Biofield Energy Treated samples, whereas the peak area% i.e. the 
relative amount of the phytoconstituents was significantly altered. The peak area% at Rt of 5.1, 5.7, 6.4, 6.6, 6.9, 7.1, 7.4, 
7.8, 7.9, 8.0, 8.2, 8.5, and 8.9 minutes of the treated sample were increased in the range of 0.92% to 14.67% compared to 
the control sample. On the contrary, the peak area% of the treated sample at Rt of 5.2, 5.3, 5.4, 5.6, 6.8, 8.1, 8.4, 8.6, 9.0, 
9.1, and 9.2 minutes were decreased by 1.59% to 36.69% with respect to the control sample. A total of 14 withanolides such 
as sitoindoside IX, dihydrowithanolide D, withanolide A, withaferin A, ixocarpalactone A, withanolide S, withanolide 
sulfoxide, etc. were proposed with their structure from the molecular mass at m/z 605, 489, 473, 471, 505, and 992 at 
retention times of 6.9, 7.1, 7.9, 8.2, 8.5, and 9.3 minutes with the help of LC-MS, GC-MS and NMR data of both the control 
and Biofield Energy Treated samples. Consequently, the mass peak intensities of the treated sample were significantly 
changed in the range of -36.67% to 106% compared with the control sample at the same retention time. These findings 
suggest that Energy of Consciousness Healing Treatment could be advantageous for altering the concentration of the 
phytoconstituents in the ashwagandha root extract by modifying their intrinsic physicochemical properties, which might be 
helpful to improve the bioavailability of active constituents of ashwagandha extract that might provide better therapeutic 
response against inflammatory diseases, immunological disorders, arthritis, stress, cancer, diabetes, sexual disorders, aging, 
and other chronic infections.  
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1. Introduction 
Withania somnifera is an ancient herb commonly known as 
ashwagandha, winter cherry and ‘Indian ginseng’ used 
worldwide as herbal medicines for the prevention and 
treatment of many diseases and for the good health [1-3]. 
Ashwagandha is mostly used in the herbal drugs and 
nutraceuticals for the treatment sexual and nervous disorders, 
infectious diseases, diabetes, cancer, immunological 
disorders, ulcer, stress, arthritis, etc. It is used as a tonic to 
rejuvenate the body, arrest the aging process, and boost the 
defense system against infectious disorders as well as to 
promote the longevity of life [2-6]. The major active 
phytoconstituents of W. somnifera root extract are majorly 
withanolides. Besides withanolides, ashwagandha root 
contains alkaloids, numerous withanamides, sitoindosides, 
reducing sugars, peroxidases, glycosides, starch, dilcitol, 
withanicil, benzyl alcohol, 2-phenyl ethanol, 3,4,5-trihydroxy 
cinnamic acid, phenyl acetic acid, benzoic acid, etc. [7-9]. 
Isolated withanolides from W. somnifera possess various 
pharmacological activities include antioxidant, 
neuroprotective, immunomodulating, hepatoprotective, 
anticancer, anti-inflammatory, hypoglycaemic, antiarthritic, 
antimicrobial, etc. [10-12]. Thus, ashwagandha root extract 
was considered as one of the components in a novel 
proprietary herbomineral formulation, and it can be used for 
the prevention and treatment of various human disorders.  
A unique vital force preserved by every living organisms 
which is usually believed to create the source of life is co-
related with the soul, spirit and mind and is also recognized 
as prana by the Hindus, ki by the Japanese, and qi or chi by 
the Chinese, from the ancient-time. Now-a-days, this 
hypothetical vital force is considered as the Bioenergetics 
Field. This energy field is infinite, paradimensional and 
dynamic electromagnetic field surrounding the human body. 
This is also known as Biofield Energy. It can easily flow 
between the human and environment that leads to the 
continuous movement or matter of energy [13, 14]. Thus, the 
human has the capability to harness energy from the earth, 
the “Universal Energy Field” and transmit it to any living or 
nonliving object(s) around the globe. The objects always 
receive the energy and respond in a useful way. This process 
is known as “Biofield Energy Healing Treatment” [15-17]. 
Biofield (Putative Energy Fields) based Energy Therapies 
have been practiced worldwide in different health disease 
profiles [18]. The National Center of Complementary and 
Integrative Health (NCCIH) has been recognized and 
accepted Biofield Energy Healing as a Complementary and 
Alternative Medicine (CAM) health care approach in 
addition to other therapies, medicines and practices such as 
natural products, deep breathing, yoga, Qi Gong, Tai Chi, 
chiropractic/osteopathic manipulation, meditation, special 
diets, massage, homeopathy, progressive relaxation, 
acupressure, acupuncture, guided imagery, relaxation 
techniques, hypnotherapy, movement therapy, healing touch, 
pilates, rolfing structural integration, Ayurvedic medicine, 
mindfulness, alternative Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, cranial sacral 
therapy, Reiki, and applied prayer (as is common in all 
religions, like Hinduism, Christianity, Buddhism and 
Judaism) [19]. The Biofield Energy Treatment (The Trivedi 
Effect
®
) has been extensively studied with significant 
outcomes in many scientific fields such as cancer research 
[20]; altered antimicrobial sensitivity of pathogenic microbes 
in genetics [21, 22], biotechnology [23, 24], microbiology 
[25-27], changing the structure of the atom in various metals, 
ceramics, polymers and chemicals materials science [28-30], 
altered chemical and physical properties of organic 
compounds [31-33], pharmaceuticals [34, 35], nutraceuticals 
[36, 37], and improved overall growth and yield of plants in 
agricultural science [38, 39]. 
Modern sophisticated instrumental techniques such as 
high-performance liquid chromatography (HPLC) with 
photodiode array and evaporative light scattering detection, 
ultra-performance liquid chromatography, electrospray 
ionization (ESI) normally hyphenated with gas 
chromatography (GC), mass spectrometry (MS), nuclear 
magnetic resonance (NMR) are very useful for the metabolite 
profiling and identification of the crude herbal extract [8, 40-
42]. The LC-MS/MS, GC-MS and NMR analysis of W. 
somnifera hydroalcoholic root extract revealed the presence 
of several known withanolides including withanolide D, 
withaferin A, withanoside IV or VI, withanolide sulfoxide, 
etc. along with two new withanolides i.e. dihydrowithanolide 
D and ixocarpalactone A [43]. For this reason, LC-MS/MS, 
GC-MS, and NMR analysis were conducted in this study for 
the profiling and structure elucidation of the 
phytoconstituents of the Energy of Consciousness Healing 
Treatment (The Trivedi Effect
®
) ashwagandha 
hydroalcoholic root extract. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
Ashwagandha (Withania somnifera) root hydroalcoholic 
extract was procured from Sanat Product Ltd., India. The 
HPLC grade Milli Q water and acetonitrile were purchased 
from Millipore and Merck. All other chemicals used in the 
experiment were of analytical grade available in India. 
2.2. Energy of Consciousness Healing Treatment Strategies 
Ashwagandha root extract was one of the components of 
the new proprietary herbomineral formulation, developed by 
our research team and it was used per se as a test compound 
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for the current study. The test compound was divided into 
two parts, one part of the test compound was treated with 
Energy of Consciousness Healing Treatment (The Trivedi 
Effect
®
) by renowned Biofield Energy Healers and defined as 
Biofield Energy Treated sample. The second part of the test 
compound did not receive any sort of treatment and defined 
as untreated or control ashwagandha root extract sample. 
This Biofield Energy Treatment was provided by the group 
of twenty renowned Biofield Energy Healers who 
participated in this study and performed the Biofield Energy 
Treatment remotely. Thirteen Biofield Energy Healers were 
remotely located in the U.S.A., five were located in Canada, 
and two were located in Australia, while the test compound 
was located in the research laboratory of GVK Biosciences 
Pvt. Ltd., Hyderabad, India. This Biofield Energy Treatment 
was provided for 5 minutes through Healer’s Unique Energy 
Transmission process remotely to the test compound under 
the laboratory conditions. None of the Biofield Energy 
Healers in this study visited the laboratory in person, nor had 
any contact with the compounds. Similarly, the control 
compound was subjected to “sham” healers for 5 minutes, 
under the same laboratory conditions. The sham healer did 
not have any knowledge about the Biofield Energy Healing 
Treatment. The Biofield Energy Treated and untreated 
samples were kept in similar sealed conditions and 
characterized thoroughly by LC-MS, GC-MS and NMR 
spectroscopy.  
2.3. Characterization 
2.3.1. Liquid Chromatography Mass Spectrometry (LC-MS) 
The LC-MS analysis of the test samples were conducted 
by following the almost same method as mentioned in the 
recent literature [43] using The Waters
®
 ACQUITY UPLC, 
Milford, MA, USA equipped with a binary pump (The 
Waters
®
 BSM HPLC pump), autosampler, column heater and 
a photo-diode array (PDA) detector. A Triple Quad (Waters 
Quattro Premier XE, USA) mass spectrometer equipped with 
an electrospray ionization (ESI) source was used for the mass 
spectrometric analysis. The control and Biofield Energy 
Treated extract powders were dissolved in dimethylsulfoxide 
to afford a 1 mg/mL stock solution. An aliquot of 2 µL of the 
stock solution was used for LC-MS analysis with a total run 
time of 25 minutes. Mass spectra were recorded in the 
positive ionization mode and with the full scan (m/z 50-
1400). 
Percent change in peak area% (P) was calculated using 
following equation (1): 
%	change	in	peak	area% =


× 100      (1) 
Where, PControl and PTreated are the peak area (%) of the 
control and Biofield Energy Treated samples, respectively. 
Similarly, the percent change in mass peak intensity (I) 
was calculated using following equation (2): 
%	change	in	mass	peak	intensity =
#	#	
#	
× 100                                                               (2) 
Where, IControl and ITreated are the mass peak intensity of the 
control and Biofield Energy Treated samples, respectively. 
2.3.2. Gas Chromatography-Mass Spectrometry (GC-MS) 
Analysis 
GC-MS analysis of the test samples were analyzed by 
following the same procedure as mentioned in the recent 
scientific literature [43] with the help of Agilent 7890B with 
5977A Mass selective detector, USA equipped with a 
Quadrupole detector with pre-filter and flame ionization 
detector (FID). The control and Biofield Energy Treated 
extract powders were dissolved in dimethylsulfoxide to 
afford a 1 mg/mL stock solution. An aliquot of 1.0 µL of the 
stock solution was injected with a total run time of 44.0 min. 
The identification of analyte was performed using the 
retention time with a comparison of the mass spectra of the 
identified substances with references. 
2.3.3. Nuclear Magnetic Resonance (NMR) Spectroscopy 
Analysis 
1
H NMR and 
13
C NMR analysis of the test samples extract 
powders were performed on
 
a 400 MHZ VARIAN FT-NMR 
spectrometer and 100.00 MHz on a VARIAN FT-NMR 
spectrometer, respectively using the same procedure as 
mentioned in the recent literature [43]. 
1
H NMR 
multiplicities were labelled as singlet (s), doublet (d), doublet 
of doublet (dd), triplet (t), quartet (q), multiplet (m), broad 
(br), apparent (app). Chemical shifts (δ) were in parts per 
million (ppm) relative to the solvent’s residual proton 
chemical shift (CD3OD, δ = 3.31, 4.80 ppm) and solvent’s 
residual carbon chemical shift (CD3OD, δ = 49.15 ppm).  
3. Results and Discussion 
The liquid chromatography chromatograms and the 
chromatographic data of the control and Biofield Energy 
Treated samples of ashwagandha root extract are presented in 
Figure 1 and Table 1. The LC chromatograms of the control 
and Biofield Energy Treated samples showed several peaks at 
different retention times. The control and Biofield Energy 
Treated samples shown the 24 definite peaks in the 
chromatogram at Rt of 5.1, 5.2, 5.3, 5.4, 5.6, 5.7, 6.4, 6.6, 
6.8, 6.9, 7.1, 7.4, 7.8, 7.9, 8.0, 8.1, 8.2, 8.4, 8.5, 8.6, 8.9, 9.0, 
9.1, and 9.2 minutes. The Biofield Energy Treated sample 
along with 24 peaks, three additional peaks appeared at Rt of 
5.81, 8.58, and 8.81 minutes (Figure 1) which did not detect 
in the control sample (Figure 1). A change in the retention 
time along with the appearance and disappearance of some 
peaks was observed in the Biofield Energy Treated sample 
compared with the control sample. Thus, the polarity of some 
of the phytoconstituents in the Biofield Energy Treated 
ashwagandha root extract was altered compared with the 
control sample. Each of the corresponding Rt represents the 
presence of one phytoconstituents from the ashwagandha 
root extract. The Rt of both the control and Biofield Energy 
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Treated samples were very close to each other (Table 1). The 
peak heights/areas were very important for the measurement 
of the relative quantities of the compounds present in the 
sample. The height/area under the peak is directly 
proportional to the relative amount of each compound, which 
had passed the detector, and these areas can be calculated. 
The peak area% of phytoconstituents present in the 
Biofield Energy Treated ashwagandha root extract was 
increased in the range of 0.92% to 14.67% at Rt of 5.1, 5.7, 
6.4, 6.6, 6.9, 7.1, 7.4, 7.8, 7.9, 8.0, 8.2, 8.5, and 8.9 minutes 
compared with the control sample (Table 1). Similarly, the 
peak area% of some of the other phytoconstituents in the 
Biofield Energy Treated ashwagandha was decreased in the 
range of 1.59% to 36.69% at Rt of 5.2, 5.3, 5.4, 5.6, 6.8, 8.1, 
8.4, 8.6, 9.0, 9.1, and 9.2 minutes, respectively compared 
with the control sample (Table 1). The peak area% of the 
phytoconstituents in the Biofield energy Treated 
ashwagandha root extract was altered significantly in the 
range of -36.69% to 14.67% compared with the control 
sample (Table 1). The peak area% provides the relative 
concentration of components in the chromatogram, when all 
components respond in the detector and are eluted [43, 44]. It 
is assumed that all the components in both the samples were 
equally responded in the detector. Table 1 revealed that 
Biofield Energy Healing Treatment might have the 
significant effect on the relative amount/concentration of the 
phytoconstituents. It is assumed that the intrinsic 
physicochemical properties of ashwagandha root extract such 
as morphology, particle size, shape, etc. of the compounds 
that are related to the solubility of the compounds might have 
altered due to the Biofield Energy Healing Treatments [28-
35].  
 
Figure 1. Liquid chromatograms of the control and Biofield Energy Treated W. somnifera root extract. 
Table 1. Liquid chromatographic data of the control and Biofield Energy Treated W. somnifera root extract. 
Peak 
WS-Control WS-Biofield Energy 
Change in PA% 
Rt PA PA% PA PA% 
1 5.1 4758.53 1.84 6361.95 2.11 14.67 
2 5.2 1008.25 0.39 1041.93 0.35 -10.26 
3 5.3 3529.39 1.36 3321.84 1.10 -19.12 
4 5.4 4389.99 1.69 3224.82 1.07 -36.69 
5 5.6 3972.84 1.53 3619.44 1.20 -21.57 
6 5.7 5008.86 1.93 6106.93 2.03 5.18 
7 6.4 7565.69 2.92 9265.79 3.08 5.48 
8 6.6 8618.03 3.33 10471.39 3.48 4.50 
9 6.8 4577.27 1.77 5087.22 1.69 -4.52 
10 6.9 1855.85 0.72 2416.25 0.80 11.11 
11 7.1 47669.68 18.40 55938.64 18.57 0.92 
12 7.4 2107.19 0.81 2677.30 0.89 9.88 
13 7.8 7198.31 2.78 8645.08 2.87 3.24 
14 7.9 8915.69 3.44 11310.46 3.76 9.30 
15 8.0 2689.22 1.04 3171.87 1.05 0.96 
16 8.1 81752.41 31.56 92861.20 30.83 -2.31 
17 8.2 13574.26 5.24 16518.82 5.48 4.58 
18 8.4 22861.84 8.83 26186.50 8.69 -1.59 
19 8.5 5255.02 2.03 6882.82 2.29 12.81 
20 8.6 2626.57 1.01 2258.86 0.75 -25.74 
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Peak 
WS-Control WS-Biofield Energy 
Change in PA% 
Rt PA PA% PA PA% 
21 8.9 1691.83 0.65 2115.10 0.70 7.69 
22 9.0 1337.64 0.52 1448.85 0.48 -7.69 
23 9.1 1977.50 0.76 1755.62 0.58 -23.68 
24 9.2 14088.15 5.44 15775.32 5.24 -3.68 
Total peak area 259030.01  301200.20   
PA: Peak Area; PH: Peak Height; TIC: Total Ion Chromatogram; Rt: Retention time; 
#denotes the percentage change in the peak area (%) of the Biofield 
Energy Treated sample with respect to the control sample. 
Table 2. Compounds proposed from ESI-MS spectra of the control and Biofield Energy Treated ashwagandha root extract. 
Rt (min) ESI-MS (m/z) Proposed Compounds 
m/z peak Intensity % Change 
in Intensity* Control Treated 
6.9 
650 [M + NH4]
+ 
471 [M - 163]+ 
Sitoindoside IX (1) 1.81e6 2.27e6 25.41 
7.1 489 [M + H]+ β-hydroxy-2,3-dihydro-withanolide F (2) 2.33e7 1.63e7 -30.04 
7.9 473 [M + H]+ 
24,25-dihydrowithanolide D (3)  
2,3-dihydrowithaferin A (4) 
1.23e7 7.79e6 -36.67 
8.2 471 [M + H]+ 
Withanolide A (5) 
Withaferine A (6) 
Withanone (7) 
Withanolide D (8) 
27-Hydroxy withanolide B (9) 
5,7,α-Epoxy-6α,20α-dihydroxy-1-oxowitha-2,24-dienolide (10) 
5α,17-Dihydroxy-6α,7α-epoxy-1-oxo-witha-2,24-dienolide (11) 
6.78e7 7.12e7 5.02 
8.5 
505 [M + H]+ 
488 [M - 16]+ 
Ixocarpalactone A (12) 
Withanolide S (13) 
9.97e6 9.74e6 -2.31 
9.2 992 [M + H]+ Withanolide sulfoxide (14) 1.16e6 2.39e6 106 
*denotes the percentage change of the Biofield Energy Treated sample with respect to the control sample. 
Among these 24 peaks, only six peaks at the Rt of 6.9, 7.1, 
7.9, 8.2, 8.5, and 9.3 minutes having higher peak area% than 
other Rt responded to the mass spectrometric analysis and 
afforded the respective ESI-MS spectra (Table 2). From the 
ESI-MS spectra, a total of 14 withanolides shown in the 
Figure 2 were proposed along with the help GC-MS, NMR 
data and according to the approach described in our recent 
literature [43]. 
The Sitoindoside IX (1) (Figure 2) was proposed from the 
ammonium adduct ion peak at m/z 650 [M + NH4]
+
 (calcd for 
C34H52NO11, 650) along with daughter ion mass m/z 471 [M -
163]
+ 
in the mass spectra of the control and Biofield Energy 
Treated sample at Rt of 6.9 minutes. The peak area% of 
sitoindoside IX (1) was significantly increased by 11.11% 
and the peak intensity at m/z 650 was significantly increased 
by 25.41% in the Biofield Energy Treated sample compared 
to the control sample (Tables 2). Similarly, at Rt of 7.1 
minutes 3β-hydroxy-2,3-dihydro-withanolide F (2) was 
identified with molecular ion peak m/z 489 [M+H]
+
 
(calculated for C28H40O7, 489) (Table 2 and Figure 2) in the 
mass spectra of the control and Biofield Energy Treated 
sample. The peak area% was increased slightly by 0.92%, but 
the peak intensity at m/z 489 was decreased by 30.04% in the 
Biofield Energy Treated sample compared to the control 
sample (Tables 1 & 2). Similarly, the withanolides like 24,25-
dihydrowithanolide D (3) or 2,3-dihydrowithaferin A (4) 
identified with molecular ion peak at m/z 473 (calculated for 
C28H40O6, 473) were proposed [43] at the Rt of 7.9 min 
(Table 2 and Figure 2). The peak area% was increased 
significantly by 9.30%, but the peak intensity at m/z 473 was 
decreased by 47.52% in the Biofield Energy Treated sample 
compared to the control sample (Tables 1 & 2). 
With the help of the recent literature [43], withanolide A 
(5) or withaferin A (6) or withanone (7) or withanolide D (8) 
or 27-hydroxy withanolide B (9) or 5,7,α-epoxy-6α,20α-
dihydroxy-1-oxowitha-2,24-dienolide (10) or 5α,17-
dihydroxy-6α,7α-epoxy-1-oxo-witha-2,24-dienolide (11) 
(Figure 2) can show the molecular ion peak with m/z 471 [M 
+ H]
+
 (calcd for C28H39O6, 471) in the ESI-MS spectra of 
both the samples at Rt of 8.2 minutes. The GC-MS (Figure 3) 
and NMR data (Figure 4) also supported the presence of any 
of compounds 11-14. The peak area% and mass peak 
intensity at m/z 471 were increased by 4.58% and 5.02%, 
respectively in the Biofield Energy Treated sample compared 
with the control sample (Tables 1 & 2). At Rt of 8.55 minutes, 
ixocarpalactone A (12) or withanolide S (13) were proposed 
with m/z 505 [M + H]
+
 (calculated for C28H40O8, 505) (Table 
2 and Figure 2). The peak area% of ixocarpalactone A (12) or 
withanolide S (13) was increased significantly by 12.81%, 
but peak intensity at m/z 505 was decreased by 2.31% in the 
Biofield Energy Treated sample compared to the control 
sample (Tables 1 & 2). Ixocarpalactone A reported to be 
promising anti-tumor agent [43]. The withanolide identified 
at Rt of 9.2 min and at m/z 992 [M + H]
+
 (calculated for 
C56H79O13S, 992) was withanolide sulfoxide (14) (Table 2 
and Figure 2). The change in peak area% of withanolide 
sulfoxide (14) was decreased slightly by 3.68%, but peak 
intensity at m/z 992 was significantly increased by 106% in 
the Biofield Energy Treated sample compared to the control 
sample (Tables 1 & 2). 
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The current LC-MS data revealed that the mass 
fragmentation pattern of both the control and Biofield Energy 
Treated samples were found almost similar. However, the 
mass peak intensities of the Biofield Energy Treated sample 
were significantly altered from the range of -36.67% to 106% 
compared with the control sample at the same retention time. 
This finding suggests that the natural isotopic abundance 
ratio of the identified phytoconstituents in the ashwagandha 
root extract might be altered due to The Trivedi Effect
® 
- 
Consciousness Energy Healing Treatment. 
 
Figure 2. Structure of the proposed compounds from W. somnifera root extract. 
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Figure 3. GC-MS spectra of the control and Biofield Energy Treated W. somnifera root extract with the proposed fragmentation of compounds. 
 
Figure 4. 1H NMR spectra of the control (a), Biofield Energy Treated (b); 13C NMR spectra of the control (c), and Biofield Energy Treated (d) W. somnifera 
root extract.  
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4. Conclusions 
The LC-MS, GC-MS, and NMR study on W. somnifera 
root extract concluded that The Trivedi Effect
®
 - Energy of 
Consciousness Healing Treatment has the significant effect 
on the peak area% i.e. the relative concentration of the 
phytoconstituents without affecting their structural 
properties. The LC-MS data revealed that the retention time 
(Rt) of the phytoconstituents remained same in the control 
and Biofield Energy Treated samples, whereas the peak 
area% i.e. the relative amount of the phytoconstituents was 
significantly altered. The peak area% at Rt of 5.1, 5.7, 6.4, 
6.6, 6.9, 7.1, 7.4, 7.8, 7.9, 8.0, 8.2, 8.5, and 8.9 minutes of the 
Biofield Energy Treated sample were increased in the range 
of 0.92% to 14.67% compared to the control sample. In the 
contrary, the peak area % of the Biofield Energy Treated 
sample at Rt of 5.2, 5.3, 5.4, 5.6, 6.8, 8.1, 8.4, 8.6, 9.0, 9.1, 
and 9.2 minutes were decreased by 1.59% to 36.69% with 
respect to the control sample. A total of 14 withanolides such 
as sitoindoside IX, dihydrowithanolide D, withanolide A, 
withaferin A, ixocarpalactone A, withanolide S, withanolide 
sulfoxide, etc. were proposed with their structure from the 
molecular mass at m/z 605, 489, 473, 471, 505, and 992 at 
retention times of 6.9, 7.1, 7.9, 8.2, 8.5, and 9.3 minutes with 
the help of LC-MS, GC-MS and NMR data of both the 
control and Biofield Energy Treated samples. The peak 
area% of the Biofield Energy Treated sample was altered 
significantly in the range of -36.69% to 14.67% compared 
with the control sample. Similarly, the mass peak intensities 
of the Biofield Energy Treated sample were significantly 
changed in the range of -36.67% to 106% compared with the 
control sample at the same retention time. The Biofield 
Energy Healing Treatment could be valuable for altering the 
concentration of the phytoconstituents in the ashwagandha 
root extract by modifying their intrinsic physicochemical 
properties, which might be helpful to improve the 
bioavailability of its phytoconstituents. Thus, Biofield 
Energy Treated W. somnifera root extract might provide 
better therapeutic response against various diseases such as 
diabetes mellitus, allergies and septic shock; stress-related 
disorders like sleep disorder, insomnia, depression, anxiety, 
Attention Deficit Disorder (ADD), Attention Deficit 
Hyperactive Disorder (ADHD), mental restlessness (mind 
chattering), low libido, brain frog, impotency, lack of 
motivation, mood swings, confusion, fear of the future, 
migraines, headaches, forgetfulness, overwhelm, loneliness, 
irritability, worthlessness, indecisiveness, frustration, chronic 
fatigue, obsessive/compulsive behavior and panic attacks; 
inflammatory diseases and immunological disorders like 
Lupus, Hashimoto Thyroiditis, Systemic Lupus 
Erythematosus, Type 1 Diabetes, Asthma, Chronic peptic 
ulcers, Tuberculosis, Chronic active hepatitis, Hepatitis, 
Celiac Disease (gluten-sensitive enteropathy), Graves’ 
Disease, Addison Disease, Crohn's disease, Pernicious and 
Sjogren Syndrome, Aplastic Anemia, Irritable Bowel 
Syndrome (IBS), Multiple Sclerosis, Rheumatoid arthritis, 
Chronic periodontitis, Ulcerative colitis, Chronic sinusitis, 
Myasthenia Gravis, Vasculitis, Atherosclerosis, Dermatitis, 
Diverticulitis, Alopecia Areata, Rheumatoid Arthritis, 
Reactive Arthritis, Psoriasis, Fibromyalgia, Scleroderma, 
Chronic Fatigue Syndrome and Vitiligo; aging-related 
diseases like cardiovascular disease, diabetes, arthritis, 
cancer, Alzheimer’s disease, dementia, cataracts, 
osteoporosis, hearing loss, hypertension, glaucoma, 
Parkinson’s Disease, Prion Disease, Huntington’s Disease, 
Motor Neuron Disease, Amyotrophic lateral sclerosis, 
Spinocerebellar Ataxia, Spinal muscular atrophy, Friedreich’s 
Ataxia and Lewy Body Disease, chronic infections and much 
more. 
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